$AGIO AGIOS PHARMACEUTICALS, INC. Insider Trading Week 49/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. in week 49/2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.45 | 631 | 38,144 | 79,515 | 80.1 K to 79.5 K (-0.79 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.45 | 631 | 38,144 | 79,475 | 80.1 K to 79.5 K (-0.79 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 59.68 | 288 | 17,188 | 80,146 | 80.4 K to 80.1 K (-0.36 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 59.68 | 288 | 17,188 | 80,106 | 80.4 K to 80.1 K (-0.36 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.01 | 204 | 12,242 | 80,434 | 80.6 K to 80.4 K (-0.25 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 60.01 | 204 | 12,242 | 80,394 | 80.6 K to 80.4 K (-0.25 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 58.95 | 254 | 14,973 | 80,638 | 80.9 K to 80.6 K (-0.31 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 58.95 | 253 | 14,914 | 80,598 | 80.9 K to 80.6 K (-0.31 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.90 | 542 | 31,382 | 80,892 | 81.4 K to 80.9 K (-0.67 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Cantley Lewis Clayton Jr. | Director | Sell | S | 57.90 | 543 | 31,440 | 80,851 | 81.4 K to 80.9 K (-0.67 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 2.34 | 31,818 | 74,375 | 31,818 | |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 102 | 48 | 4,867 | |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 14,875 | 6,954 | 0 | |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 2.34 | 31,818 | 74,375 | 53,059 | 21.2 K to 53.1 K (+149.80 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 102 | 48 | 21,241 | 21.1 K to 21.2 K (+0.48 %) |
Dec 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 14,875 | 6,954 | 21,139 | 6.3 K to 21.1 K (+237.47 %) |
Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Director | Option Exercise | A | 61.17 | 16,000 | 978,720 | 16,000 | |
Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 2,146 | 67,899 | 30,039 | |
Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 61.76 | 700 | 43,232 | 6,264 | 7 K to 6.3 K (-10.05 %) |
Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 60.63 | 846 | 51,293 | 6,964 | 7.8 K to 7 K (-10.83 %) |
Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 59.89 | 600 | 35,934 | 7,810 | 8.4 K to 7.8 K (-7.13 %) |
Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 2,146 | 67,899 | 8,410 | 6.3 K to 8.4 K (+34.26 %) |